5-Amino-1MQ

Specialized research compounds

5-Amino-1MQ

Available documentary data and items still to verify are detailed below.

Price incl. VAT€52.00
AvailabilityAvailable
SKU5-Amino

Loading availability…

02 — Information to verify

Product details

Overview

5-Amino-1MQ is a small molecule studied as an inhibitor of nicotinamide N-methyltransferase (NNMT). This enzyme connects nicotinamide metabolism with the use of methyl donors. The compound is not a peptide.

Structure and technical data

Technical data

Catalog format: 10 mg. The listed formula and mass describe the 5-amino-1-methylquinolinium cation and exclude any counterion, such as iodide. The salt form of the material requires a separate specification.

5-Amino-1MQ: 2D molecular structure
2D molecular structure — PubChem. PubChem CID 950107
Sequence
Not applicable
Molecular formula
C10H11N2+
Reported molecular mass
159.21 g/mol
CAS number
685079-15-6
PubChem CID
950107
Reported synonyms
5-amino-1-methylquinolinium; PMX593N4N3

Reference molecular data.

View the PubChem record — PubChem CID 950107

Research context

The cited studies examine NNMT inhibition in enzyme assays, adipocyte cultures, and mouse models. Measured endpoints include 1-methylnicotinamide, lipid accumulation, and metabolic responses. Results depend on the model and do not establish clinical benefits of the product.

NNMT targeting and methyl-group flux

NNMT transfers a methyl group from S-adenosylmethionine (SAM) to nicotinamide, forming 1-methylnicotinamide. Inhibitor research measures enzyme activity, cell entry, and selectivity. Reduced 1-methylnicotinamide is a target-related readout, distinct from changes in weight or body composition.

10.1016/j.bcp.2017.11.007

Adipocyte differentiation

In 3T3-L1 cultures, preadipocyte-to-adipocyte differentiation allows lipid accumulation and nicotinamide metabolism to be studied. Interpretation distinguishes cell number, maturation state, and lipid content per cell. NAD+ and SAM provide additional information about the metabolic state of the system.

10.1016/j.bcp.2017.11.007

Lipid synthesis and energy balance

Lipid synthesis, storage, and oxidation are separate processes. Experimental systems can distinguish them using lipid content, oxygen consumption, and metabolite measurements. PPAR pathways and lipogenesis factors provide biological context; without direct data, they cannot be listed as established 5-Amino-1MQ targets.

10.1016/j.bcp.2017.11.007

Adipokines and the inflammatory microenvironment

Adipose tissue produces leptin, adiponectin, and inflammatory mediators as well as storing energy. Background publications examine how these signals interact with metabolism and other tissues. They do not automatically establish that 5-Amino-1MQ changes each adipokine or has antitumour activity.

10.3390/diagnostics11030494

Mouse models and interpretation of findings

The 2018 NNMT-inhibitor study includes a high-fat-diet mouse model. Findings concern defined compounds, exposures, and experimental conditions.

10.1016/j.bcp.2017.11.007

References

Catalog of products presented for research activities. Not for human or veterinary use. This notice does not replace verification of applicable rules.